HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Non-fatal disseminated mucormycosis in a solid organ transplant].

AbstractBACKGROUND:
Mucormycosis is a rare fungal infection occurring most frequently in immunocompromised patients. The pathogens are filamentous fungi, order of Mucorales. Disseminated mucormycosis is a severe, life treating disease. Early diagnosis is a major determinant for prognosis, however, it remains difficult. The management consists in an early antifungal therapy using lipid formulation of amphotericin B associated with an extensive surgical debridement. Despite this therapeutic of choice, the mortality of disseminated mucormycosis remains high.
OBSERVATION:
We report the case of disseminated mucormycosis in a 25 years old woman 9 months after a pulmonary transplantation. The clinical presentation included pulmonary and thyroid localization and the pathogen was Absidia corymbifera. The patient survived thanks to a large surgical debridement, and an early antifungal bitherapy by lipid formulation of amphotericin B and posaconazole.
CONCLUSION:
The re-emergence and the high mortality of mucormycosis in solid organ transplant receiver show the necessity to find new therapeutic approaches. Posaconazole associated with liposomal amphotericin B could be an interesting option to treat disseminated mucormycosis and improve their outcome.
AuthorsC Minet, A Bonadona, A Tabah, A Karkas, L Mescam, C Schwebel, R Hamidfar, C Pison, C Saint-Raymond, O Faure, D Salameire, J-F Timsit
JournalRevue des maladies respiratoires (Rev Mal Respir) Vol. 26 Issue 9 Pg. 998-1002 (Nov 2009) ISSN: 1776-2588 [Electronic] France
Vernacular TitleMucormycose disséminée d'évolution favorable chez une greffée pulmonaire.
PMID19953048 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antifungal Agents
  • Triazoles
  • posaconazole
  • Amphotericin B
Topics
  • Absidia
  • Adult
  • Amphotericin B (administration & dosage)
  • Antifungal Agents (administration & dosage)
  • Combined Modality Therapy
  • Debridement
  • Female
  • Humans
  • Lung Diseases, Fungal (diagnosis, surgery)
  • Lung Transplantation
  • Mucormycosis (diagnosis, drug therapy, surgery)
  • Opportunistic Infections (diagnosis, drug therapy, surgery)
  • Thyroid Diseases (diagnosis, surgery)
  • Triazoles (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: